Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab

Dermatology Online Journal

Volumn 18, Issue 9, 2012, Pages

  Romero Maté, Alberto ^a   Martínez Sánchez, Diego ^a   Tardío, Juan C ^a   Moreno Torres, Amalia ^a   García Donoso, Carmen ^a   Aguado Lobo, Marta ^a   Espinosa Lara, Pablo ^a   Borbujo, Jesús ^a  

^a HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTINUCLEAR ANTIBODY; DNA ANTIBODY; MEGLUMINE ANTIMONATE; METHOTREXATE; TOLL LIKE RECEPTOR 9; MEGLUMINE; MEGLUMINE ANTIMONIATE; MONOCLONAL ANTIBODY; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; CASE REPORT; CELLULAR IMMUNITY; CLINICAL FEATURE; FEMALE; FOLLOW UP; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; LEISHMANIA INFANTUM; MEDICAL HISTORY; NONHUMAN; POLYMERASE CHAIN REACTION; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUNCH BIOPSY; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN GRANULOMA; SKIN INFLAMMATION; SKIN LEISHMANIASIS; TH17 CELL; TREATMENT OUTCOME; BLOOD; DRUG COMBINATION; GRANULOMA; MIDDLE AGED; PATHOLOGY;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; GRANULOMA; HUMANS; LEISHMANIASIS, CUTANEOUS; MEGLUMINE; METHOTREXATE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS;

EID: 84866458495     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Liew FY, Parkinson C, Millott S, Severn A, Carrier M. Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis. Immunology. 1990;69:570-3. [PubMed]
2. Wilhelm P, Wiede F, Meissner A, Donhauser N, Bogdan C, Körner H. TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice. Microbes Infect. 2005 Dec;7(15):1461-8. Epub 2005 Jul 5. [PubMed]
3. Sitter U, Lechner A, Scharl K, Kiafard Z, Zwirner J, Körner H. TNF controls the infiltration of dendritic cells into the site of Leishmania major infection. Med Microbiol Immunol. 2008 Mar;197(1):29-37. Epub 2007 Jul 28 [PubMed]
4. Sassi A, Larguèche-Darwaz B, Collette A, Six A, Laouini D, Cazenave PA, Dellagi K. Mechanisms of the natural reactivity of lymphocytes from noninfected individuals to membrane-associated Leishmania infantum antigens. J Immunol. 2005 Mar 15;174(6):3598-607 [PubMed]
5. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol. 2002 May 1;168(9):4620-7 [PubMed]
6. Fabre S, Gibert C, Lechiche C, Dereure J, Jorgensen C, Sany J. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab. Clin Exp Rheumatol. 2005 Nov-Dec;23(6):891-2 [PubMed]
7. Romaní-Costa V, Sánchez C, Moyá F, Estany C. [Visceral leishmaniasis related to infliximab administration]. Enferm Infecc Microbiol Clin. 2004 May;22(5):310. Spanish. [PubMed]
8. Kritikos K, Haritatos E, Tsigkos S, Gounari P, Skrapari I, Gounaris T, Sioula E. An atypical presentation of visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with infliximab. J Clin Rheumatol. 2010 Jan;16(1):38-9. [PubMed]
9. Tektonidou MG, Skopouli FN. Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection? Clin Rheumatol. 2008 Apr;27(4):541-2. Epub 2007 Oct 26 [PubMed]
10. De Leonardis F, Govoni M, Lo Monaco A, Trotta F. Visceral leishmaniasis and anti-TNF-alpha therapy: case report and review of the literature. Clin Exp Rheumatol. 2009;27:503-6 [PubMed]
11. Bassetti RM, Pizzorni C, Gradoni L, Del Bono V, Cutolo M, Viscoli C. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab. Rheumatology 2006;45:1446-1448. [PubMed]
12. Moltó A, Mateo L, Lloveras N, Olivé A, Minguez S. Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab. Joint Bone Spine 2010;77:271-273 [PubMed]
13. Bagalas V, Kioumis I, Argyropoulou P, Patakas D. Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept. Clin Rheumatol 2007;26:1344-1345. [PubMed]
14. Mueller MC, Fleischmann E, Grunke M, Schewe S, Bogner JR, Löscher T. Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab. Am J Trop Med Hyg. 2009;81:52-4 [PubMed]
15. Baltà-Cruz S, Alsina-Glbert M, Mozos-Rocafort A, Cervera C, Colomo-Saperas L, Del Río A, Estrach-Panella T. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis. Acta Derm Venereol. 2009;89(4):432-3 [PubMed]
16. Schneider P, Bouaziz JD, Foulet F, Duong TA, Allanore LV, Bagot M. [Multifocal cutaneous leishmaniasis due to Leishmania infantum under adalimumab therapy]. Ann Dermatol Venereol. 2009 Nov;136(11):815-6. Epub 2009 Oct 9. French. [PubMed]
17. Tuon FF, Fernandes ER, Pagliari C, Duarte MI, Amato VS. The expression of TLR9 in human cutaneous leishmaniasis is associated with granuloma. Parasite Immunol. 2010 Nov-Dec;32(11-12):769-72. [PubMed]
18. Ito T, Schaller M, Hogaboam CM, et al. TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. J Clin Invest. 2009;119:33-46.
19. Okamoto Yoshida Y, Umemura M, Yahagi A, O'Brien RL, Ikuta K, Kishihara K, Hara H, Nakae S, Iwakura Y, Matsuzaki G. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol. 2010 Apr 15;184(8):4414-22. Epub 2010 Mar 8. [PubMed]
20. Rutitzky LI, Lopes da Rosa JR, Stadecker MJ. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol. 2005 Sep 15;175(6):3920-6. [PubMed]
21. Zanger P, Kötter I, Kremsner PG, Gabrysch S. Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe. Clin Microbiol Infect. 2011 Sep 14. Epub ahead of print. [PubMed]